§ 13F · FUND PROFILE
Rosalind Advisors, Inc..
Institutional filer · behavioral pattern: Other. Summary pending.
AUM · $292.6T (13F)Positions · 39Turnover · — · Q4Filed · Feb 12, 2026
CONCENTRATION
—
Top 10 holdings
NEW BUYS
0
+$25.4T deployed
EXITS
0
No exits
SECTOR SHIFT
—
No prior quarter data
3YR HIT RATE
—
Top-5 overlap
§ 01 · TOP HOLDINGS
The book · Q4 2025
FILED FEB 12, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q4 |
|---|---|---|---|---|---|---|
| 1 | DCTH | DELCATH SYSTEMS, INC. | 3.30M | $33.0T | 11.6% | ±0% |
| 2 | SVRA | SAVARA INC | 3.40M | $20.5T | 7.2% | −15% |
| 3 | FENC | FENNEC PHARMACEUTICALS INC | 2.61M | $20.1T | 7.1% | +26% |
| 4 | XERS | XERIS BIOPHARMA HOLDGS INC | 2.11M | $16.6T | 5.8% | +18% |
| 5 | VRDN | VIRIDIAN THERAPEUTICS INC | 450K | $14.0T | 4.9% | −25% |
| 6 | MDWD | MEDIWOUND LTD | 749K | $13.8T | 4.9% | ±0% |
| 7 | VSTM | VERASTEM INC | 1.79M | $13.8T | 4.9% | −7% |
| 8 | REPL | REPLIMUNE GROUP INC | 1.41M | $13.7T | 4.8% | NEW |
| 9 | ATYR | ASTRIA THERAPEUTICS INC | 1.04M | $13.6T | 4.8% | ±0% |
| 10 | HELP | CYBIN INC | 1.66M | $13.6T | 4.8% | +11% |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE ROSALIND SIGNAL
AC read
Rosalind Advisors, Inc. is a Other fund managing $292563.5 trillion in assets. The fund runs a portfolio of 39 positions.
Read the full dossier →§ 04 · FILING HISTORY
Q-by-Q deltas
1 FILINGS
Q4 2025
Steady book
+0 buys · −0 exits · 0 changed
Q3 2025
Steady book
+0 buys · −0 exits · 0 changed
Q1 2025
Steady book
+0 buys · −0 exits · 0 changed